Neoleukin Therapeutics Volatility
| NLTXDelisted Stock | USD 0.69 0.01 1.43% |
We have found twenty-three technical indicators for Neoleukin Therapeutics, which you can use to evaluate the volatility of the firm. Please verify Neoleukin Therapeutics' Mean Deviation of 2.25, risk adjusted performance of (0.03), and Standard Deviation of 3.7 to check out if the risk estimate we provide is consistent with the expected return of 0.0%. Key indicators related to Neoleukin Therapeutics' volatility include:
690 Days Market Risk | Chance Of Distress | 690 Days Economic Sensitivity |
Neoleukin Therapeutics Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Neoleukin daily returns, and it is calculated using variance and standard deviation. We also use Neoleukin's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Neoleukin Therapeutics volatility.
Neoleukin |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Neoleukin Therapeutics can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Neoleukin Therapeutics at lower prices. For example, an investor can purchase Neoleukin stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Neoleukin Therapeutics' stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.
Moving against Neoleukin Stock
| 0.63 | HPQ | HP Inc | PairCorr |
| 0.62 | CSCO | Cisco Systems Aggressive Push | PairCorr |
| 0.6 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
| 0.59 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
| 0.58 | SSNLF | Samsung Electronics | PairCorr |
| 0.58 | TLKMF | Telkom Indonesia Tbk | PairCorr |
| 0.55 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.54 | BAC | Bank of America Aggressive Push | PairCorr |
| 0.54 | CVX | Chevron Corp Sell-off Trend | PairCorr |
Neoleukin Therapeutics Market Sensitivity And Downside Risk
Neoleukin Therapeutics' beta coefficient measures the volatility of Neoleukin stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Neoleukin stock's returns against your selected market. In other words, Neoleukin Therapeutics's beta of -0.97 provides an investor with an approximation of how much risk Neoleukin Therapeutics stock can potentially add to one of your existing portfolios. Neoleukin Therapeutics exhibits very low volatility with skewness of -2.77 and kurtosis of 13.95. Neoleukin Therapeutics is a potential penny stock. Although Neoleukin Therapeutics may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Neoleukin Therapeutics. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Neoleukin instrument if you perfectly time your entry and exit. However, remember that penny delisted stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
3 Months Beta |Analyze Neoleukin Therapeutics Demand TrendCheck current 90 days Neoleukin Therapeutics correlation with market (Dow Jones Industrial)Neoleukin Beta |
Neoleukin standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 0.0 |
It is essential to understand the difference between upside risk (as represented by Neoleukin Therapeutics's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Neoleukin Therapeutics' daily returns or price. Since the actual investment returns on holding a position in neoleukin stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Neoleukin Therapeutics.
Neoleukin Therapeutics Stock Volatility Analysis
Volatility refers to the frequency at which Neoleukin Therapeutics delisted stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Neoleukin Therapeutics' price changes. Investors will then calculate the volatility of Neoleukin Therapeutics' stock to predict their future moves. A delisted stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile delisted stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Neoleukin Therapeutics' volatility:
Historical Volatility
This type of delisted stock volatility measures Neoleukin Therapeutics' fluctuations based on previous trends. It's commonly used to predict Neoleukin Therapeutics' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Neoleukin Therapeutics' current market price. This means that the delisted stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Neoleukin Therapeutics' to be redeemed at a future date.Transformation |
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.
Neoleukin Therapeutics Projected Return Density Against Market
Given the investment horizon of 90 days Neoleukin Therapeutics has a beta of -0.9684 . This indicatesMost traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Neoleukin Therapeutics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Neoleukin Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Neoleukin delisted stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Neoleukin Therapeutics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Predicted Return Density |
| Returns |
What Drives a Neoleukin Therapeutics Price Volatility?
Several factors can influence a delisted stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Neoleukin Therapeutics Stock Return Volatility
Neoleukin Therapeutics historical daily return volatility represents how much of Neoleukin Therapeutics delisted stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The company inherits 0.0% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7444% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About Neoleukin Therapeutics Volatility
Volatility is a rate at which the price of Neoleukin Therapeutics or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Neoleukin Therapeutics may increase or decrease. In other words, similar to Neoleukin's beta indicator, it measures the risk of Neoleukin Therapeutics and helps estimate the fluctuations that may happen in a short period of time. So if prices of Neoleukin Therapeutics fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. Neoleukin Therapeutics, Inc. was founded in 2003 and is headquartered in Seattle, Washington. Neoleukin Therapeutics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 79 people.
Neoleukin Therapeutics' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Neoleukin Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Neoleukin Therapeutics' price varies over time.
3 ways to utilize Neoleukin Therapeutics' volatility to invest better
Higher Neoleukin Therapeutics' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Neoleukin Therapeutics stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Neoleukin Therapeutics stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Neoleukin Therapeutics investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Neoleukin Therapeutics' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Neoleukin Therapeutics' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Neoleukin Therapeutics Investment Opportunity
Dow Jones Industrial has a standard deviation of returns of 0.74 and is 9.223372036854776E16 times more volatile than Neoleukin Therapeutics. 0 percent of all equities and portfolios are less risky than Neoleukin Therapeutics. You can use Neoleukin Therapeutics to protect your portfolios against small market fluctuations. The stock experiences a somewhat bearish sentiment, but the market may correct it shortly. Check odds of Neoleukin Therapeutics to be traded at $0.6693 in 90 days.Good diversification
The correlation between Neoleukin Therapeutics and DJI is -0.2 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Neoleukin Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Neoleukin Therapeutics Additional Risk Indicators
The analysis of Neoleukin Therapeutics' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Neoleukin Therapeutics' investment and either accepting that risk or mitigating it. Along with some common measures of Neoleukin Therapeutics stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | 0.1957 | |||
| Mean Deviation | 2.25 | |||
| Coefficient Of Variation | (2,179) | |||
| Standard Deviation | 3.7 | |||
| Variance | 13.69 | |||
| Information Ratio | (0.08) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar delisted stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Neoleukin Therapeutics Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
| Alphabet vs. Neoleukin Therapeutics | ||
| Ford vs. Neoleukin Therapeutics | ||
| Microsoft vs. Neoleukin Therapeutics | ||
| Salesforce vs. Neoleukin Therapeutics | ||
| GM vs. Neoleukin Therapeutics | ||
| Visa vs. Neoleukin Therapeutics | ||
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Neoleukin Therapeutics as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Neoleukin Therapeutics' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Neoleukin Therapeutics' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Neoleukin Therapeutics.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in Neoleukin Stock
If you are still planning to invest in Neoleukin Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neoleukin Therapeutics' history and understand the potential risks before investing.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |